Our Pricing

Omeprazole vs Gaviscon for Acid Reflux Treatment

Published on: June 03, 2026

When comparing omeprazole vs gaviscon uk treatments, understanding how each medication works is essential for effective acid reflux management. Omeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production, whilst Gaviscon is an antacid that forms a protective barrier to prevent reflux. At Cured Pharmacy, we offer prescription omeprazole from £9.99 following a free online consultation with UK prescribers.

How Omeprazole and Gaviscon Work Differently

Omeprazole belongs to a class of medications called proton pump inhibitors (PPIs), which work by blocking the enzyme system responsible for producing stomach acid [1]. By reducing acid secretion at the cellular level, omeprazole can decrease stomach acid production by up to 90% within 24 hours of the first dose [1]. This makes it particularly effective for treating conditions caused by excessive acid production, including gastro-oesophageal reflux disease (GORD), peptic ulcers, and erosive oesophagitis.

Gaviscon, by contrast, is an alginate-based antacid that works through a mechanical rather than chemical mechanism. When Gaviscon reaches the stomach, it reacts with stomach acid to form a gel-like raft that floats on top of stomach contents [2]. This physical barrier helps prevent acid from rising into the oesophagus during reflux episodes. Gaviscon also contains antacids like sodium alginate and calcium carbonate that neutralise existing stomach acid, providing rapid symptom relief.

The fundamental difference lies in prevention versus treatment: omeprazole prevents acid production before it occurs, whilst Gaviscon manages acid that has already been produced. This distinction determines which treatment is more appropriate for different types and severities of acid reflux.

Speed of Action: Which Provides Faster Relief?

Gaviscon typically provides symptom relief within 3-5 minutes of administration, making it the faster option for immediate heartburn relief [2]. The antacid components neutralise existing acid quickly, whilst the alginate barrier forms almost instantly to prevent further reflux episodes. This rapid action makes Gaviscon ideal for occasional heartburn or breakthrough symptoms.

Omeprazole requires more time to achieve its therapeutic effect. Whilst some acid suppression begins within 1-2 hours, maximum acid reduction typically occurs after 2-4 days of consistent daily dosing [1]. Clinical trials demonstrate that omeprazole reaches peak effectiveness after approximately one week of regular use, when steady-state plasma concentrations are achieved [3]. Patients often notice progressive symptom improvement during this initial period.

When Immediate Relief Matters

For acute heartburn episodes requiring immediate relief, Gaviscon remains the preferred first-line option. However, patients experiencing frequent symptoms (more than twice weekly) may benefit more from omeprazole's sustained acid suppression, even though initial relief takes longer. Many UK prescribers recommend using Gaviscon for breakthrough symptoms whilst establishing omeprazole therapy during the first week of treatment.

Duration of Effect and Dosing Frequency

Omeprazole provides 24-hour acid suppression with once-daily dosing, typically taken in the morning before breakfast [1]. The medication's long duration of action results from its mechanism of irreversibly binding to proton pumps in gastric parietal cells. New acid pumps must be synthesised before acid production can resume, which takes approximately 18-24 hours. This extended effect means patients maintain consistent acid control throughout the day and night with a single dose.

Gaviscon's protective effect lasts approximately 4 hours per dose, requiring multiple administrations throughout the day for continuous protection [2]. Most patients take Gaviscon after meals and before bedtime—typically 3-4 times daily. The alginate raft gradually disperses as stomach contents empty, necessitating repeat dosing to maintain the protective barrier. This more frequent dosing schedule can be less convenient but allows flexible, on-demand use for symptom management.

Effectiveness for Different Types of Acid Reflux

Clinical evidence demonstrates omeprazole's superior efficacy for moderate to severe GORD and erosive oesophagitis. In randomised controlled trials, omeprazole achieved complete heartburn resolution in 70-85% of patients with erosive oesophagitis after 4-8 weeks of treatment, compared to 40-50% with antacids [3]. The medication is particularly effective for patients with nocturnal reflux symptoms, Barrett's oesophagus, or those requiring healing of oesophageal erosions.

Gaviscon proves most effective for mild, intermittent heartburn and postprandial reflux symptoms. Studies show alginate-based formulations reduce reflux episodes by approximately 50% compared to placebo, with particular benefit for post-meal symptoms [2]. Gaviscon is often recommended as first-line therapy for pregnancy-related heartburn, where minimising systemic medication exposure is preferred. It's also suitable for patients who experience reflux primarily when lying down or after specific trigger foods.

For patients with documented hiatus hernia or those who have failed lifestyle modifications, omeprazole typically provides more comprehensive symptom control than Gaviscon alone. However, combination therapy—using omeprazole for baseline acid suppression and Gaviscon for breakthrough symptoms—represents an evidence-based approach for difficult-to-control reflux.

Severity-Based Treatment Selection

The National Institute for Health and Care Excellence (NICE) recommends a stepped approach to reflux management. Patients with infrequent symptoms (less than twice weekly) may manage effectively with Gaviscon or lifestyle changes alone. Those with frequent symptoms, night-time reflux, or symptoms affecting quality of life should consider omeprazole or alternative PPIs following clinical assessment [4]. Your UK prescriber will evaluate symptom frequency, severity, and any alarm features to determine the most appropriate treatment.

Side Effects and Safety Considerations

Omeprazole is generally well-tolerated, with most side effects being mild and transient. Common effects include headache (reported in 2-7% of patients), gastrointestinal disturbances such as nausea or diarrhoea (3-4%), and abdominal pain (2-3%) [1]. Long-term PPI use has been associated with reduced magnesium absorption, slightly increased fracture risk with prolonged high-dose therapy, and potential interactions with medications like clopidogrel. The MHRA recommends using the lowest effective dose for the shortest duration necessary.

Gaviscon has an excellent safety profile with minimal systemic absorption, as it works locally in the gastrointestinal tract. The most common side effects are constipation or diarrhoea, depending on the formulation's salt content [2]. Patients with kidney disease should exercise caution with sodium-containing formulations, whilst those on calcium-restricted diets should consider calcium content. Gaviscon is considered safe during pregnancy and breastfeeding, making it a preferred option for women requiring reflux treatment during these periods.

Drug interactions differ significantly between the two treatments. Omeprazole can affect the absorption of pH-dependent medications and is metabolised by the CYP2C19 enzyme system, creating potential interactions with warfarin, diazepam, and certain antiretroviral medications [3]. Gaviscon can reduce absorption of some antibiotics and thyroid medications if taken simultaneously, but these interactions are easily managed by spacing doses 2-4 hours apart.

Cost and Accessibility: Omeprazole vs Gaviscon UK

At Cured Pharmacy, omeprazole capsules are available from £9.99 following a free online consultation with UK prescribers. As a prescription-only medication in the UK, omeprazole requires clinical assessment to ensure appropriate use and dosing. Generic omeprazole offers identical efficacy to branded versions at significantly lower cost, with our transparent pricing displayed before consultation. Patients requiring long-term treatment often find prescription omeprazole more cost-effective than purchasing over-the-counter antacids repeatedly.

Gaviscon is available over the counter without prescription, with various formulations including liquid, tablets, and sachets. Pricing varies by formulation and pack size, with regular use potentially costing more over time than prescription PPI therapy. Many patients find the convenience of purchasing Gaviscon without consultation beneficial for occasional use, though those requiring frequent dosing may prefer the once-daily convenience and cost-effectiveness of omeprazole.

For patients with persistent symptoms requiring ongoing treatment, prescription omeprazole through Cured Pharmacy offers better value than repeated Gaviscon purchases. Our UK-registered clinical team provides free assessment in under 3 minutes, with discreet delivery of genuine UK-licensed medications. Alternative PPIs including lansoprazole, pantoprazole, and esomeprazole are also available if omeprazole proves unsuitable.

Choosing Between Treatments at Cured Pharmacy

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team can help determine whether omeprazole or over-the-counter alternatives are most appropriate for your symptoms. The online consultation considers symptom frequency, severity, previous treatments tried, and any contraindications to ensure safe, effective prescribing. With transparent upfront pricing and lowest price guarantees, Cured Pharmacy makes prescription reflux treatment accessible and affordable across the UK.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. Kwiatek, M. A., Roman, S., Fareeduddin, A., Pandolfino, J. E., & Kahrilas, P. J. (2011). An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients. Alimentary Pharmacology & Therapeutics, 34(1), 59-66. https://doi.org/10.1111/j.1365-2036.2011.04678.x [accessed 13 August 2026]
3. Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J. (2009). Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology, 65(1), 19-31. https://doi.org/10.1007/s00228-008-0576-5 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.